HK1255895A1 - Composition for inhibiting migration of endotoxin into blood - Google Patents

Composition for inhibiting migration of endotoxin into blood

Info

Publication number
HK1255895A1
HK1255895A1 HK18114979.6A HK18114979A HK1255895A1 HK 1255895 A1 HK1255895 A1 HK 1255895A1 HK 18114979 A HK18114979 A HK 18114979A HK 1255895 A1 HK1255895 A1 HK 1255895A1
Authority
HK
Hong Kong
Prior art keywords
endotoxin
blood
composition
inhibiting migration
migration
Prior art date
Application number
HK18114979.6A
Other languages
Chinese (zh)
Inventor
Hisae Kume
Keiko Okazaki
Kinya Ashida
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of HK1255895A1 publication Critical patent/HK1255895A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK18114979.6A 2016-01-22 2018-11-22 Composition for inhibiting migration of endotoxin into blood HK1255895A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016010840 2016-01-22
PCT/JP2017/001856 WO2017126645A1 (en) 2016-01-22 2017-01-20 Composition for inhibiting migration of endotoxin into blood

Publications (1)

Publication Number Publication Date
HK1255895A1 true HK1255895A1 (en) 2019-08-30

Family

ID=59362471

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114979.6A HK1255895A1 (en) 2016-01-22 2018-11-22 Composition for inhibiting migration of endotoxin into blood

Country Status (6)

Country Link
JP (1) JP7383874B2 (en)
CN (1) CN108472331A (en)
HK (1) HK1255895A1 (en)
SG (1) SG11201805957QA (en)
TW (1) TW201735942A (en)
WO (1) WO2017126645A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023106078A1 (en) * 2021-12-10 2023-06-15 森永乳業株式会社 Nutritional composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (en) * 1990-03-14 1991-09-19 Nitsche Dietrich USE OF LACTOFERRINE TO CONTROL THE TOXIC EFFECT OF ENDOTOXIN
JPH07278013A (en) * 1994-03-31 1995-10-24 Snow Brand Milk Prod Co Ltd Neutralizing agent for endotoxin
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP4672163B2 (en) * 2000-03-24 2011-04-20 明治乳業株式会社 A composition for inducing specific antibody production against lipid A of gram-negative bacteria.
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
TWI612902B (en) * 2009-11-30 2018-02-01 Meiji Co Ltd Use of a composition for manufacturing an improved intestinal functional composition and preparation method thereof
CN103957720B (en) * 2011-11-30 2016-05-25 株式会社明治 Improving intestinal flora alimentation composition
JP5501416B2 (en) 2012-08-08 2014-05-21 本田技研工業株式会社 Transmission cooling duct for saddle riding type vehicles

Also Published As

Publication number Publication date
SG11201805957QA (en) 2018-08-30
JPWO2017126645A1 (en) 2018-11-08
JP7383874B2 (en) 2023-11-21
WO2017126645A1 (en) 2017-07-27
TW201735942A (en) 2017-10-16
CN108472331A (en) 2018-08-31

Similar Documents

Publication Publication Date Title
HK1245247A1 (en) Inhibitors of bromodomains
IL254518A0 (en) Compositions and methods for inhibiting gene expression of factor xii
HK1258062A1 (en) Methods of administering elagolix
HUE056172T2 (en) Compositions of selenoorganic compounds and methods of use thereof
HK1252852A1 (en) Compositions and methods for inhibiting gene expression of hif2alpha
IL257061A (en) Inhibitors of ezh2
PL3349743T3 (en) Methods and compositions of inhibiting dcn1-ubc12 interaction
IL259856A (en) Composition for treatment of crigler-najjar syndrome
HK1257689A1 (en) COMPOSITION FOR INCREASING EXPRESSION OF PGC-1α
GB2555968B (en) Controlled activation of extended-life cement compositions
HK1255221A1 (en) Methods of treatment using cadotril compositions
PT3283097T (en) Composition for treatment of infertility
HK1252057A1 (en) Novel method of use and compositions
DK3302573T3 (en) COMPOSITION FOR THE TREATMENT OF BRAIN LESSIONS
HK1258438A1 (en) Preparation method of 2-mercaptobenzothiazole
GB2539420B (en) Determination of chromatography conditions
HK1255895A1 (en) Composition for inhibiting migration of endotoxin into blood
GB2558700B (en) 4-substituted Analogs of Cytisine
IL247645A0 (en) Compositions of selenoorganic compounds and methods of use thereof
GB201513188D0 (en) Method of tomography
TWM490285U (en) Descending stopper of curtain set
TWM490377U (en) Improved structure of C clamp
PT3335729T (en) Etanercept composition having improved stability
GB201502834D0 (en) Composition of objects
GB201508443D0 (en) Methods of identifying USP-binding compounds